Children & HIV: Research: 1996-2001
- Protease Inhibitors in Children: Combination Therapy Reduced Death by Two Thirds (November 23, 2001)
To read PDF, click here.
In AIDS Treatment News, from AIDS Treatment News
On TheBodyPRO.com
- Thinning Bones Found in HIV+ Girls (April 23, 2001)
From Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- HAART-Associated Bone Mineral Loss Through Increased Rate of Bone Turnover in Vertically HIV-Infected Children (February 8, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Virologic and Immunologic Responses in Children With Advanced HIV Disease on a New HAART Regimen (PACTG 366) (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- HIV-Infected Children on HAART Reconstitute Tetanus-Specific T Cell Responses Without Booster Vaccination (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Mitochondrial and Mitochondrial-Like Symptoms in Children Born to HIV-Infected Mothers. Exhaustive Evaluation in a Large Prospective Cohort (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Is Simplification of HAART Safe in HIV-Infected Children? First Pediatric Switch Study (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Immunologic Reconstitution in Children and Adolescents Treated with HAART (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Pharmacologic Characteristics of Efavirenz and Nelfinavir Associated With Virologic Response in HIV-Infected Children (February 5, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Therapeutic Drug Monitoring of Amprenavir Combined With Ritonavir as Salvage Therapy in HIV-1-Infected Patients (July 11, 2000)
In The XIII International AIDS Conference, from TheBodyPRO.com
- Benefits and Barriers of Early Detection of HIV Infection Among Adolescents (July 7, 2000)
In SHOP Talk: School Health Opportunities and Progress Bulletin, from Sexuality Information and Education Council of the United States
- Early Therapy of Vertical HIV-1 Infection: Evidence for Cessation of Viral Replication and Absence of Virus-Specific Immunity (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Immune Reconstitution and Viral Load Response in Antiretroviral-Naive Vertically HIV-Infected Children Enrolled in the PENTA 5 Trial (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Response to Childhood Immunizations in HIV-Infected Children Treated With Potent Combination Antiretroviral Therapy (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Nucleoside Analogs Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Controlled Trial (January 26, 2000)
In Journal of the American Medical Association
- Pediatric Study Group (Winter 1999/2000)
In Women's Treatment News, from PWA Health Group
- Triple-Drug Combination Pediatric Trial (Winter 1999/2000)
Do the results support our federal treatment guidelines?.
In Women's Treatment News, from PWA Health Group
- A Phase I Study of Hydroxyurea in HIV-Infected Children Receiving Didanosine and/or Stavudine (February 2, 1999)
In The 6th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Reassuring Findings About Infants Exposed to Zidovudine (January 12, 1999)
From U.S. National Institute of Allergy and Infectious Diseases
- Making Treatment Decisions in Children With HIV (October 1998)
In AIDS Care, from San Francisco General Hospital
- Study Shows Efavirenz Promising in Treating Pediatric HIV Infection (September 28, 1998)
Leads to approval of new drug for treating HIV-infected children.
From U.S. National Institute of Allergy and Infectious Diseases
|
Advertisement
|
Email
Glossary
